Clinical trials open for enrollment are listed alphabetically. Click on the title to view the details. A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047AM2) Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
Clinical trials open for enrollment are listed alphabetically. Click on the title to view the details.
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047AM2) Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Effects of TNF-Alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047AM2)
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
